NEURAL
CELL THERAPY
Neural × Immune
Our most active line of work, though not the whole of our research. We investigate engineered cell-therapy architectures adapted for neuroinflammatory and neurodegenerative disease, where the target is a pathogenic glial or immune cell population within the nervous system rather than a tumour. The programme is organised around construct design, safety modelling and neural mechanism readouts.
Research focus
Cell engineering research
Construct design, transduction efficiency, and vector-free delivery approaches evaluated across donor-derived neural and immune co-cultures.
Safety and tolerability studies
Cytokine and neuroinflammatory release characterisation, on-target/off-tissue modelling, and engineered safety-switch evaluation in vitro.
Mechanism investigation
Single-cell readouts of neural-immune interaction, expansion, exhaustion and memory phenotype to explain why a construct behaves as it does.
